JASPER THERAPEUTICS INC
(NASDAQ: JSPR)

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.

29.640

+0.820 (+2.85%)
Range 29.360 - 31.000   (5.59%)
Open -
Previous Close 28.820
Bid Price 1.780
Bid Volume 10
Ask Price 1.850
Ask Volume 10
Volume 95,881
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis